Loading clinical trials...
Loading clinical trials...
This clinical trial will use the amyloid-binding radiotracer, 124I-evuzamitide, to potentially detect amyloid, in the heart and elsewhere, in patients who have a history of lumbar spinal stenosis and/...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
University of Tennessee Graduate School of Medicine
Collaborators
NCT06427304 · Cardiac Amyloidosis
NCT04992572 · Lumbar Spinal Stenosis
NCT05029726 · Lumbar Spinal Stenosis, Lumbar Disc Herniation, and more
NCT05058287 · Opioid Use, Lumbar Spinal Stenosis, and more
NCT07306949 · Transthyretin-type Cardiac Amyloidosis
University of Tennessee Graduate School of Medicine
Knoxville, Tennessee
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions